{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:28:40Z","timestamp":1740137320826,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Yunnan Provincial Science and Technology Department Applied Basic Research Project","award":["2017FH001\u2010088"],"award-info":[{"award-number":["2017FH001\u2010088"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10238-020-00645-0","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T13:02:25Z","timestamp":1594558945000},"page":"577-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of pathological changes and related factors in liver tissue of HBeAg-negative patients with low HBsAg levels"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-4931","authenticated-orcid":false,"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingrong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,12]]},"reference":[{"key":"645_CR1","unstructured":"WHO and CDC fact sheets. www.who.int and www.odc.gov."},{"key":"645_CR2","first-page":"1","volume":"122","author":"FM Lu","year":"2009","unstructured":"Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J. 2009;122:1\u20132.","journal-title":"Chin Med J"},{"key":"645_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30576","author":"WJ Jeng","year":"2019","unstructured":"Jeng WJ, Hsu YC, Su TH. Deliberations more than a cut-off HBsAg value for Nuc cessation. Hepatology. 2019. https:\/\/doi.org\/10.1002\/hep.30576.","journal-title":"Hepatology"},{"issue":"8","key":"645_CR4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/jvh.12889","volume":"25","author":"B Wang","year":"2018","unstructured":"Wang B, Carey I, Bruce M, Montague S, Dusheiko G, Agarwal K. HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues. J Viral Hepat. 2018;25(8):886\u201393. https:\/\/doi.org\/10.1111\/jvh.12889.","journal-title":"J Viral Hepat"},{"issue":"7","key":"645_CR5","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/23744235.2018.1442018","volume":"50","author":"ML Wang","year":"2018","unstructured":"Wang ML, Liao J, Wei B, et al. Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy. Infect Dis. 2018;50(7):522\u201330. https:\/\/doi.org\/10.1080\/23744235.2018.1442018.","journal-title":"Infect Dis"},{"issue":"11","key":"645_CR6","doi-asserted-by":"publisher","first-page":"e0188303","DOI":"10.1371\/journal.pone.0188303","volume":"12","author":"T Broquetas","year":"2017","unstructured":"Broquetas T, Garcia-Retortillo M, Hernandez JJ, et al. Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues. PLoS ONE. 2017;12(11):e0188303. https:\/\/doi.org\/10.1371\/journal.pone.0188303.","journal-title":"PLoS ONE"},{"issue":"8","key":"645_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3851\/imp1696","volume":"15","author":"TH Su","year":"2010","unstructured":"Su TH, Hsu CS, Chen CL, et al. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antivir Ther. 2010;15(8):1133\u20139. https:\/\/doi.org\/10.3851\/imp1696.","journal-title":"Antivir Ther"},{"issue":"4","key":"645_CR8","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/hep.23803","volume":"52","author":"HL Chan","year":"2010","unstructured":"Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, Sung JJ. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology. 2010;52(4):1232\u201341. https:\/\/doi.org\/10.1002\/hep.23803.","journal-title":"Hepatology"},{"key":"645_CR9","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/hep.23571","volume":"51","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Nguyen T, Lser D. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intra-hepatic hepatitis B virus markers. Hepatology. 2010;51:1933\u201344.","journal-title":"Hepatology"},{"issue":"4","key":"645_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jhep.2010.01.014","volume":"52","author":"J Jaroszewicz","year":"2010","unstructured":"Jaroszewicz J, Calle Serrano B, Wursthorn K, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol. 2010;52(4):514\u201322. https:\/\/doi.org\/10.1016\/j.jhep.2010.01.014.","journal-title":"J Hepatol"},{"issue":"9","key":"645_CR11","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00705-009-0474-x","volume":"154","author":"B Ozdil","year":"2009","unstructured":"Ozdil B, Cosar AM, Akkiz H, Sandikci MU, Kece C. Negative correlation between viral load and HBsAg levels in chronic HBV-infected patients. Adv Virol. 2009;154(9):1451\u20135. https:\/\/doi.org\/10.1007\/s00705-009-0474-x.","journal-title":"Adv Virol"},{"issue":"3","key":"645_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10238-015-0372-3","volume":"16","author":"V Pazienza","year":"2016","unstructured":"Pazienza V, Panebianco C, Andriulli A. Hepatitis viruses exploitation of host DNA methyltransferases functions. Clin Exp Med. 2016;16(3):265\u201372. https:\/\/doi.org\/10.1007\/s10238-015-0372-3.","journal-title":"Clin Exp Med"},{"issue":"2","key":"645_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10238-017-0480-3","volume":"18","author":"LY Wang","year":"2018","unstructured":"Wang LY, Fan YC, Zhao J, Ji XF, Wang K. Increased BATF expression is associated with the severity of liver damage in patients with chronic hepatitis B. Clin Exp Med. 2018;18(2):263\u201372. https:\/\/doi.org\/10.1007\/s10238-017-0480-3.","journal-title":"Clin Exp Med"},{"issue":"2","key":"645_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/j.gastro.2010.04.052","volume":"139","author":"MR Brunetto","year":"2010","unstructured":"Brunetto MR, Oliveri F, Colombatto P, et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology. 2010;139(2):483\u201390. https:\/\/doi.org\/10.1053\/j.gastro.2010.04.052.","journal-title":"Gastroenterology"},{"issue":"7","key":"645_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1365-2893.2011.01465.x","volume":"18","author":"MJ Sonneveld","year":"2011","unstructured":"Sonneveld MJ, Zoutendijk R, Janssen HL. Hepatitis B surface antigen monitoring and management of chronic hepatitis B. J Viral Hepat. 2011;18(7):449\u201357. https:\/\/doi.org\/10.1111\/j.1365-2893.2011.01465.x.","journal-title":"J Viral Hepat"},{"issue":"4","key":"645_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jcv.2014.01.013","volume":"59","author":"Z Tan","year":"2014","unstructured":"Tan Z, Li M, Kuang X, et al. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2014;59(4):228\u201334. https:\/\/doi.org\/10.1016\/j.jcv.2014.01.013.","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"issue":"8","key":"645_CR17","first-page":"511","volume":"7","author":"TT Tran","year":"2011","unstructured":"Tran TT. Immune tolerant hepatitis B: a clinical dilemma. Gastroenterol Hepatol. 2011;7(8):511\u20136.","journal-title":"Gastroenterol Hepatol"},{"issue":"11\u201312","key":"645_CR18","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/j.1365-2036.2011.04888.x","volume":"34","author":"JW Jang","year":"2011","unstructured":"Jang JW, Yoo SH, Kwon JH, et al. Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection. Aliment Pharmacol Ther. 2011;34(11\u201312):1337\u201346. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04888.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"645_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/liv.12075","volume":"33","author":"M Martinot-Peignoux","year":"2013","unstructured":"Martinot-Peignoux M, Lapalus M, Asselah T, Marcellin P. The role of HBsAg quantification for monitoring natural history and treatment outcome. Liver Int Off J Int Assoc Study Liver. 2013;33(Suppl 1):125\u201332. https:\/\/doi.org\/10.1111\/liv.12075.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"1","key":"645_CR20","first-page":"20","volume":"19","author":"W Lu","year":"2016","unstructured":"Lu W, Zhang ZQ, Shen F. Serum HBsAg levels and HBV DNA loads in prediction of hepatic histological activity grading and fibrosis staging in patients with chronic hepatitis B. J Pract Hepatol. 2016;19(1):20\u20135.","journal-title":"J Pract Hepatol"},{"issue":"17","key":"645_CR21","first-page":"3893","volume":"25","author":"HF Qiu","year":"2015","unstructured":"Qiu HF, Li JH, Yang WJ. Analysis of related factors of liver pathology in patients with chronic hepatitis B infection sustained normal alanine aminotransferase. Chin J Nosocomiol. 2015;25(17):3893\u20135.","journal-title":"Chin J Nosocomiol"},{"issue":"9","key":"645_CR22","doi-asserted-by":"publisher","first-page":"e0203220","DOI":"10.1371\/journal.pone.0203220","volume":"13","author":"YF Xing","year":"2018","unstructured":"Xing YF, Zhou DQ, He JS, et al. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: a multicentre-based study in China. PLoS ONE. 2018;13(9):e0203220. https:\/\/doi.org\/10.1371\/journal.pone.0203220.","journal-title":"PLoS ONE"},{"issue":"8","key":"645_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cgh.2013.11.038","volume":"12","author":"LH Nguyen","year":"2014","unstructured":"Nguyen LH, Chao D, Lim JK, Ayoub W, Nguyen MH. Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic review. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12(8):1262\u20136. https:\/\/doi.org\/10.1016\/j.cgh.2013.11.038.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"2","key":"645_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/meg.0000000000001023","volume":"30","author":"Z Lin","year":"2018","unstructured":"Lin Z, Liang J, Zhu J, et al. Diverse correlations between fibrosis-related factors and liver stiffness measurement by transient elastography in chronic hepatitis B. Eur J Gastroenterol Hepatol. 2018;30(2):217\u201325. https:\/\/doi.org\/10.1097\/meg.0000000000001023.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"645_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jcv.2018.01.012","volume":"101","author":"KH Shin","year":"2018","unstructured":"Shin KH, Lee HJ, Chang CL, Kim HH. Performance of the cobas Hepatitis B virus (HBV) test using the cobas 4800 system and comparison of HBV DNA quantification ability between the COBAS AmpliPrep\/COBAS TaqMan HBV test version 2.0 and cobas HBV test. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2018;101:47\u201351. https:\/\/doi.org\/10.1016\/j.jcv.2018.01.012.","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"issue":"4","key":"645_CR26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/hep.22760","volume":"49","author":"MR Brunetto","year":"2009","unstructured":"Brunetto MR, Moriconi F, Bonino F, et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology. 2009;49(4):1141\u201350. https:\/\/doi.org\/10.1002\/hep.22760.","journal-title":"Hepatology"},{"issue":"11","key":"645_CR27","doi-asserted-by":"publisher","first-page":"e0186660","DOI":"10.1371\/journal.pone.0186660","volume":"12","author":"H Xiao","year":"2017","unstructured":"Xiao H, Shi M, Xie Y, Chi X. Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: a systematic review and meta-analysis. PLoS ONE. 2017;12(11):e0186660. https:\/\/doi.org\/10.1371\/journal.pone.0186660.","journal-title":"PLoS ONE"},{"issue":"3","key":"645_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10238-019-00560-z","volume":"19","author":"R Liu","year":"2019","unstructured":"Liu R, Guo J, Lu Y, et al. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy. Clin Exp Med. 2019;19(3):309\u201320. https:\/\/doi.org\/10.1007\/s10238-019-00560-z.","journal-title":"Clin Exp Med"},{"issue":"4","key":"645_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clinre.2014.05.002","volume":"38","author":"A Dezsofi","year":"2014","unstructured":"Dezsofi A, Knisely AS. Liver biopsy in children 2014: Who, whom, what, when, where, why? Clin Res Hepatol Gastroenterol. 2014;38(4):395\u20138. https:\/\/doi.org\/10.1016\/j.clinre.2014.05.002.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"645_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0168-8278(95)80269-x","volume":"22","author":"PJ Scheuer","year":"1995","unstructured":"Scheuer PJ. The nomenclature of chronic hepatitis: time for a change. J Hepatol. 1995;22(1):112\u20134. https:\/\/doi.org\/10.1016\/0168-8278(95)80269-x.","journal-title":"J Hepatol"},{"issue":"3","key":"645_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/cei.12028","volume":"171","author":"S Zhu","year":"2013","unstructured":"Zhu S, Zhang H, Dong Y, et al. The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B. Clin Exp Immunol. 2013;171(3):307\u201312. https:\/\/doi.org\/10.1111\/cei.12028.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"645_CR32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/hep.26916","volume":"59","author":"J Zhao","year":"2014","unstructured":"Zhao J, Zhang Z, Luan Y, et al. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology. 2014;59(4):1331\u201342. https:\/\/doi.org\/10.1002\/hep.26916.","journal-title":"Hepatology"},{"key":"645_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cca.2018.02.015","volume":"481","author":"C Liu","year":"2018","unstructured":"Liu C, Wu W, Shang H, et al. Prediction value of serum HBV large surface protein in different phases of HBV infection and virological response of chronic hepatitis B patients. Clin Chim Acta Int J Clin Chem. 2018;481:12\u20139. https:\/\/doi.org\/10.1016\/j.cca.2018.02.015.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"5","key":"645_CR34","first-page":"369","volume":"13","author":"HB Ding","year":"2010","unstructured":"Ding HB, Li YX, Lai JQ. Analysis of the correlation between pathological changes and inner diameter of portal vein in liver tissue of patients with chronic hepatitis B. J Prac Hepatol. 2010;13(5):369\u201370.","journal-title":"J Prac Hepatol"},{"issue":"18","key":"645_CR35","first-page":"1411","volume":"95","author":"Q Wang","year":"2015","unstructured":"Wang Q, Li X, Hu K, Zhao K, Yang P, Liu B. Logistic regression model of noninvasive prediction for portal hypertensive gastropathy in patients with hepatitis B associated cirrhosis. Zhonghua yi xue za zhi. 2015;95(18):1411\u20134.","journal-title":"Zhonghua yi xue za zhi"},{"issue":"3","key":"645_CR36","first-page":"243","volume":"45","author":"KO Akande","year":"2016","unstructured":"Akande KO, Akere A, Otegbayo JA, Ola SO, Ousunmade D. Accuracy of non-endoscopic predictors of oesophageal varices in liver cirrhosis using platelet count, splenic size and portal vein diameter. Afr J Med Med Sci. 2016;45(3):243\u201351.","journal-title":"Afr J Med Med Sci"},{"issue":"6","key":"645_CR37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/meg.0000000000000853","volume":"29","author":"ZST Veiga","year":"2017","unstructured":"Veiga ZST, Villela-Nogueira CA, Fernandes FF, et al. Transient elastography evaluation of hepatic and spleen stiffness in patients with hepatosplenic schistosomiasis. Eur J Gastroenterol Hepatol. 2017;29(6):730\u20135. https:\/\/doi.org\/10.1097\/meg.0000000000000853.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"645_CR38","first-page":"360","volume":"18","author":"XP Huo","year":"2015","unstructured":"Huo XP, Xie QX, Jiang XP. Pathological changes of liver tissues in 486 patients with chronic hepatitis B. J Prac Hepatol. 2015;18(4):360\u20133.","journal-title":"J Prac Hepatol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-020-00645-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T23:25:59Z","timestamp":1626045959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-020-00645-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,12]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1007\/s10238-020-00645-0","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"type":"print","value":"1591-8890"},{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2020,7,12]]},"assertion":[{"value":"30 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee (Third People\u2019s Hospital of Kunming +2014010512) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The need for individual consent was waived by the committee because of the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}